Literature DB >> 11099480

Impaired beta-cell regeneration in perinatally malnourished rats: a study with STZ.

A Garofano1, P Czernichow, B Bréant.   

Abstract

We investigated the mechanisms implicated in beta-cell mass reduction observed during late fetal and early postnatal malnutrition in the rat. Beta-cell regeneration, including proliferation and neogenesis, was studied after neonatal beta-cell destruction by streptozotocin (STZ). STZ was injected at birth and maternal food restriction was continued until weaning. Beta-cell mass, proliferation, and islet number were quantified by morphometrical measurements on pancreatic sections in STZ-injected normal (C-STZ) and malnourished (R-STZ) rats, with noninjected C and R rats as controls. At day 4, only 20% of the beta cell-mass remained in C-STZ rats. It regenerated to 50% that of noninjected controls, mainly through active neogenesis, as shown by the entire recovery of islet number/cm(2), and also through moderately increased beta-cell proliferation. In contrast, beta-cell mass from R-STZ animals poorly regenerated, despite a dramatic increase of beta-cell proliferation, because islet number/cm(2) recovered insufficiently. In conclusion, perinatal malnutrition impairs neogenesis and the capacity of beta-cell regeneration by neogenesis but preserves beta-cell proliferation, which remains the elective choice to increase beta-cell mass. These results provide an explanation for the impaired capacity of malnourished animals to adapt their beta-cell mass during aging or pregnancy, which aggravate glucose tolerance.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11099480     DOI: 10.1096/fj.00-0015com

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  11 in total

1.  Nutritional programming of pancreatic β-cell plasticity.

Authors:  David J Hill
Journal:  World J Diabetes       Date:  2011-08-15

2.  Ghrelin prevents development of diabetes at adult age in streptozotocin-treated newborn rats.

Authors:  T Irako; T Akamizu; H Hosoda; H Iwakura; H Ariyasu; K Tojo; N Tajima; K Kangawa
Journal:  Diabetologia       Date:  2006-03-29       Impact factor: 10.122

3.  Role of FGF1, FGF2 and FGF7 in the development of the pancreas from control and streptozotocin-treated hamsters.

Authors:  M Inchovska; V Ogneva; Y Martinova
Journal:  Cell Prolif       Date:  2006-12       Impact factor: 6.831

Review 4.  New insights into endocrine pancreatic development: the role of environmental factors.

Authors:  M Heinis; M T Simon; B Duvillié
Journal:  Horm Res Paediatr       Date:  2010-06-16       Impact factor: 2.852

5.  Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta.

Authors:  Robert S Garofalo; Stephen J Orena; Kristina Rafidi; Anthony J Torchia; Jeffrey L Stock; Audrey L Hildebrandt; Timothy Coskran; Shawn C Black; Dominique J Brees; Joan R Wicks; John D McNeish; Kevin G Coleman
Journal:  J Clin Invest       Date:  2003-07-03       Impact factor: 14.808

6.  Effects of genetics and in utero diet on murine pancreatic development.

Authors:  Chia-Lei Lin; Lyda Williams; Yoshinori Seki; Harpreet Kaur; Kirsten Hartil; Ariana Fiallo; A Scott Glenn; Ellen B Katz; Maureen J Charron; Patricia M Vuguin
Journal:  J Endocrinol       Date:  2014-06-03       Impact factor: 4.286

7.  Longitudinal noninvasive PET-based beta cell mass estimates in a spontaneous diabetes rat model.

Authors:  Fabiola Souza; Norman Simpson; Anthony Raffo; Chitra Saxena; Antonella Maffei; Mark Hardy; Michael Kilbourn; Robin Goland; Rudolph Leibel; J John Mann; Ronald Van Heertum; Paul E Harris
Journal:  J Clin Invest       Date:  2006-05-18       Impact factor: 14.808

8.  Alteration of the cardiac sympathetic innervation is modulated by duration of diabetes in female rats.

Authors:  Jitka Švíglerová; Jiří Mudra; Zbyněk Tonar; Jana Slavíková; Jitka Kuncová
Journal:  Exp Diabetes Res       Date:  2011-07-17

9.  Evaluation of a Standardized Extract from Morus alba against α-Glucosidase Inhibitory Effect and Postprandial Antihyperglycemic in Patients with Impaired Glucose Tolerance: A Randomized Double-Blind Clinical Trial.

Authors:  Seung Hwan Hwang; Hong Mei Li; Soon Sung Lim; Zhiqiang Wang; Jae-Seung Hong; Bo Huang
Journal:  Evid Based Complement Alternat Med       Date:  2016-11-16       Impact factor: 2.629

10.  A model of type 2 diabetes in the guinea pig using sequential diet-induced glucose intolerance and streptozotocin treatment.

Authors:  Brendan K Podell; David F Ackart; Michael A Richardson; James E DiLisio; Bruce Pulford; Randall J Basaraba
Journal:  Dis Model Mech       Date:  2017-01-12       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.